カテゴリー： Market Monitor Global, 世界, 医療/バイオ

アルコール性肝障害治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Hepatoprotective Drug Against Alcohol Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5614）

◆商品コード：MMG23JU5614
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hepatoprotective Drug Against Alcohol Market 調査レポートは次の情報を含め、グローバルにおけるのアルコール性肝障害治療薬市場規模と予測を収録しています。・世界のアルコール性肝障害治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のアルコール性肝障害治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアルコール性肝障害治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物性原料ベース」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

アルコール性肝障害治療薬のグローバル主要企業は、Livestamin Healthcare、 The Himalaya Drug Company、 Mysha Health World、 Chambio、 Noreva Biotech、 Finecure Pharmaceuticals Limited、 Iscon Life Sciences、 Sunflower Pharmaceutical Group Co.,ltd.、 Swisse、 By-health Co.,ltd、 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.、 Xiuzheng Pharmaceutical Industry Group Companyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、アルコール性肝障害治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のアルコール性肝障害治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のアルコール性肝障害治療薬市場：タイプ別市場シェア、2022年
・動物性原料ベース、植物性原料ベース

世界のアルコール性肝障害治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のアルコール性肝障害治療薬市場：用途別市場シェア、2022年
・薬局、病院、栄養クリニック、スーパー、その他

世界のアルコール性肝障害治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のアルコール性肝障害治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるアルコール性肝障害治療薬のグローバル売上、2018年-2023年
・主要企業におけるアルコール性肝障害治療薬のグローバル売上シェア、2022年
・主要企業におけるアルコール性肝障害治療薬のグローバル販売量、2018年-2023年
・主要企業におけるアルコール性肝障害治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Livestamin Healthcare、 The Himalaya Drug Company、 Mysha Health World、 Chambio、 Noreva Biotech、 Finecure Pharmaceuticals Limited、 Iscon Life Sciences、 Sunflower Pharmaceutical Group Co.,ltd.、 Swisse、 By-health Co.,ltd、 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.、 Xiuzheng Pharmaceutical Industry Group Company

*************************************************************

・調査・分析レポートの概要
アルコール性肝障害治療薬市場の定義
市場セグメント
世界のアルコール性肝障害治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアルコール性肝障害治療薬市場規模
世界のアルコール性肝障害治療薬市場規模：2022年 VS 2029年
世界のアルコール性肝障害治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアルコール性肝障害治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアルコール性肝障害治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：動物性原料ベース、植物性原料ベース
アルコール性肝障害治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、病院、栄養クリニック、スーパー、その他
アルコール性肝障害治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別アルコール性肝障害治療薬市場規模 2022年と2029年
地域別アルコール性肝障害治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Livestamin Healthcare、 The Himalaya Drug Company、 Mysha Health World、 Chambio、 Noreva Biotech、 Finecure Pharmaceuticals Limited、 Iscon Life Sciences、 Sunflower Pharmaceutical Group Co.,ltd.、 Swisse、 By-health Co.,ltd、 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.、 Xiuzheng Pharmaceutical Industry Group Company
...

This report aims to provide a comprehensive presentation of the global market for Hepatoprotective Drug Against Alcohol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatoprotective Drug Against Alcohol. This report contains market size and forecasts of Hepatoprotective Drug Against Alcohol in global, including the following market information:
Global Hepatoprotective Drug Against Alcohol Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatoprotective Drug Against Alcohol Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hepatoprotective Drug Against Alcohol companies in 2022 (%)
The global Hepatoprotective Drug Against Alcohol market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Based on Animal Ingredients Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatoprotective Drug Against Alcohol include Livestamin Healthcare, The Himalaya Drug Company, Mysha Health World, Chambio, Noreva Biotech, Finecure Pharmaceuticals Limited, Iscon Life Sciences, Sunflower Pharmaceutical Group Co.,ltd. and Swisse, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatoprotective Drug Against Alcohol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatoprotective Drug Against Alcohol Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatoprotective Drug Against Alcohol Market Segment Percentages, by Type, 2022 (%)
Based on Animal Ingredients
Based on Plant Ingredients
Global Hepatoprotective Drug Against Alcohol Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatoprotective Drug Against Alcohol Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Dieticians Clinic
Supermarket
Others
Global Hepatoprotective Drug Against Alcohol Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatoprotective Drug Against Alcohol Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatoprotective Drug Against Alcohol revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatoprotective Drug Against Alcohol revenues share in global market, 2022 (%)
Key companies Hepatoprotective Drug Against Alcohol sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatoprotective Drug Against Alcohol sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Livestamin Healthcare
The Himalaya Drug Company
Mysha Health World
Chambio
Noreva Biotech
Finecure Pharmaceuticals Limited
Iscon Life Sciences
Sunflower Pharmaceutical Group Co.,ltd.
Swisse
By-health Co.,ltd
Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
Xiuzheng Pharmaceutical Industry Group Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatoprotective Drug Against Alcohol, market overview.
Chapter 2: Global Hepatoprotective Drug Against Alcohol market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatoprotective Drug Against Alcohol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatoprotective Drug Against Alcohol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatoprotective Drug Against Alcohol capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hepatoprotective Drug Against Alcohol Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatoprotective Drug Against Alcohol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatoprotective Drug Against Alcohol Overall Market Size
2.1 Global Hepatoprotective Drug Against Alcohol Market Size: 2022 VS 2029
2.2 Global Hepatoprotective Drug Against Alcohol Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatoprotective Drug Against Alcohol Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatoprotective Drug Against Alcohol Players in Global Market
3.2 Top Global Hepatoprotective Drug Against Alcohol Companies Ranked by Revenue
3.3 Global Hepatoprotective Drug Against Alcohol Revenue by Companies
3.4 Global Hepatoprotective Drug Against Alcohol Sales by Companies
3.5 Global Hepatoprotective Drug Against Alcohol Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatoprotective Drug Against Alcohol Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatoprotective Drug Against Alcohol Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatoprotective Drug Against Alcohol Players in Global Market
3.8.1 List of Global Tier 1 Hepatoprotective Drug Against Alcohol Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatoprotective Drug Against Alcohol Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hepatoprotective Drug Against Alcohol Market Size Markets, 2022 & 2029
4.1.2 Based on Animal Ingredients
4.1.3 Based on Plant Ingredients
4.2 By Type – Global Hepatoprotective Drug Against Alcohol Revenue & Forecasts
4.2.1 By Type – Global Hepatoprotective Drug Against Alcohol Revenue, 2018-2023
4.2.2 By Type – Global Hepatoprotective Drug Against Alcohol Revenue, 2024-2029
4.2.3 By Type – Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
4.3 By Type – Global Hepatoprotective Drug Against Alcohol Sales & Forecasts
4.3.1 By Type – Global Hepatoprotective Drug Against Alcohol Sales, 2018-2023
4.3.2 By Type – Global Hepatoprotective Drug Against Alcohol Sales, 2024-2029
4.3.3 By Type – Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
4.4 By Type – Global Hepatoprotective Drug Against Alcohol Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hepatoprotective Drug Against Alcohol Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Dieticians Clinic
5.1.5 Supermarket
5.1.6 Others
5.2 By Application – Global Hepatoprotective Drug Against Alcohol Revenue & Forecasts
5.2.1 By Application – Global Hepatoprotective Drug Against Alcohol Revenue, 2018-2023
5.2.2 By Application – Global Hepatoprotective Drug Against Alcohol Revenue, 2024-2029
5.2.3 By Application – Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
5.3 By Application – Global Hepatoprotective Drug Against Alcohol Sales & Forecasts
5.3.1 By Application – Global Hepatoprotective Drug Against Alcohol Sales, 2018-2023
5.3.2 By Application – Global Hepatoprotective Drug Against Alcohol Sales, 2024-2029
5.3.3 By Application – Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
5.4 By Application – Global Hepatoprotective Drug Against Alcohol Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hepatoprotective Drug Against Alcohol Market Size, 2022 & 2029
6.2 By Region – Global Hepatoprotective Drug Against Alcohol Revenue & Forecasts
6.2.1 By Region – Global Hepatoprotective Drug Against Alcohol Revenue, 2018-2023
6.2.2 By Region – Global Hepatoprotective Drug Against Alcohol Revenue, 2024-2029
6.2.3 By Region – Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
6.3 By Region – Global Hepatoprotective Drug Against Alcohol Sales & Forecasts
6.3.1 By Region – Global Hepatoprotective Drug Against Alcohol Sales, 2018-2023
6.3.2 By Region – Global Hepatoprotective Drug Against Alcohol Sales, 2024-2029
6.3.3 By Region – Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hepatoprotective Drug Against Alcohol Revenue, 2018-2029
6.4.2 By Country – North America Hepatoprotective Drug Against Alcohol Sales, 2018-2029
6.4.3 US Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.4.4 Canada Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.4.5 Mexico Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hepatoprotective Drug Against Alcohol Revenue, 2018-2029
6.5.2 By Country – Europe Hepatoprotective Drug Against Alcohol Sales, 2018-2029
6.5.3 Germany Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.4 France Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.5 U.K. Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.6 Italy Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.7 Russia Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.8 Nordic Countries Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.5.9 Benelux Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hepatoprotective Drug Against Alcohol Revenue, 2018-2029
6.6.2 By Region – Asia Hepatoprotective Drug Against Alcohol Sales, 2018-2029
6.6.3 China Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.6.4 Japan Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.6.5 South Korea Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.6.6 Southeast Asia Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.6.7 India Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hepatoprotective Drug Against Alcohol Revenue, 2018-2029
6.7.2 By Country – South America Hepatoprotective Drug Against Alcohol Sales, 2018-2029
6.7.3 Brazil Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.7.4 Argentina Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hepatoprotective Drug Against Alcohol Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hepatoprotective Drug Against Alcohol Sales, 2018-2029
6.8.3 Turkey Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.8.4 Israel Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
6.8.6 UAE Hepatoprotective Drug Against Alcohol Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Livestamin Healthcare
7.1.1 Livestamin Healthcare Company Summary
7.1.2 Livestamin Healthcare Business Overview
7.1.3 Livestamin Healthcare Hepatoprotective Drug Against Alcohol Major Product Offerings
7.1.4 Livestamin Healthcare Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.1.5 Livestamin Healthcare Key News & Latest Developments
7.2 The Himalaya Drug Company
7.2.1 The Himalaya Drug Company Company Summary
7.2.2 The Himalaya Drug Company Business Overview
7.2.3 The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Major Product Offerings
7.2.4 The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.2.5 The Himalaya Drug Company Key News & Latest Developments
7.3 Mysha Health World
7.3.1 Mysha Health World Company Summary
7.3.2 Mysha Health World Business Overview
7.3.3 Mysha Health World Hepatoprotective Drug Against Alcohol Major Product Offerings
7.3.4 Mysha Health World Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.3.5 Mysha Health World Key News & Latest Developments
7.4 Chambio
7.4.1 Chambio Company Summary
7.4.2 Chambio Business Overview
7.4.3 Chambio Hepatoprotective Drug Against Alcohol Major Product Offerings
7.4.4 Chambio Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.4.5 Chambio Key News & Latest Developments
7.5 Noreva Biotech
7.5.1 Noreva Biotech Company Summary
7.5.2 Noreva Biotech Business Overview
7.5.3 Noreva Biotech Hepatoprotective Drug Against Alcohol Major Product Offerings
7.5.4 Noreva Biotech Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.5.5 Noreva Biotech Key News & Latest Developments
7.6 Finecure Pharmaceuticals Limited
7.6.1 Finecure Pharmaceuticals Limited Company Summary
7.6.2 Finecure Pharmaceuticals Limited Business Overview
7.6.3 Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Major Product Offerings
7.6.4 Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.6.5 Finecure Pharmaceuticals Limited Key News & Latest Developments
7.7 Iscon Life Sciences
7.7.1 Iscon Life Sciences Company Summary
7.7.2 Iscon Life Sciences Business Overview
7.7.3 Iscon Life Sciences Hepatoprotective Drug Against Alcohol Major Product Offerings
7.7.4 Iscon Life Sciences Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.7.5 Iscon Life Sciences Key News & Latest Developments
7.8 Sunflower Pharmaceutical Group Co.,ltd.
7.8.1 Sunflower Pharmaceutical Group Co.,ltd. Company Summary
7.8.2 Sunflower Pharmaceutical Group Co.,ltd. Business Overview
7.8.3 Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Major Product Offerings
7.8.4 Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.8.5 Sunflower Pharmaceutical Group Co.,ltd. Key News & Latest Developments
7.9 Swisse
7.9.1 Swisse Company Summary
7.9.2 Swisse Business Overview
7.9.3 Swisse Hepatoprotective Drug Against Alcohol Major Product Offerings
7.9.4 Swisse Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.9.5 Swisse Key News & Latest Developments
7.10 By-health Co.,ltd
7.10.1 By-health Co.,ltd Company Summary
7.10.2 By-health Co.,ltd Business Overview
7.10.3 By-health Co.,ltd Hepatoprotective Drug Against Alcohol Major Product Offerings
7.10.4 By-health Co.,ltd Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.10.5 By-health Co.,ltd Key News & Latest Developments
7.11 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
7.11.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Summary
7.11.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Business Overview
7.11.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Major Product Offerings
7.11.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.11.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Key News & Latest Developments
7.12 Xiuzheng Pharmaceutical Industry Group Company
7.12.1 Xiuzheng Pharmaceutical Industry Group Company Company Summary
7.12.2 Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Business Overview
7.12.3 Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Major Product Offerings
7.12.4 Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Sales and Revenue in Global (2018-2023)
7.12.5 Xiuzheng Pharmaceutical Industry Group Company Key News & Latest Developments
8 Global Hepatoprotective Drug Against Alcohol Production Capacity, Analysis
8.1 Global Hepatoprotective Drug Against Alcohol Production Capacity, 2018-2029
8.2 Hepatoprotective Drug Against Alcohol Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatoprotective Drug Against Alcohol Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatoprotective Drug Against Alcohol Supply Chain Analysis
10.1 Hepatoprotective Drug Against Alcohol Industry Value Chain
10.2 Hepatoprotective Drug Against Alcohol Upstream Market
10.3 Hepatoprotective Drug Against Alcohol Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatoprotective Drug Against Alcohol Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hepatoprotective Drug Against Alcohol in Global Market
Table 2. Top Hepatoprotective Drug Against Alcohol Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatoprotective Drug Against Alcohol Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatoprotective Drug Against Alcohol Revenue Share by Companies, 2018-2023
Table 5. Global Hepatoprotective Drug Against Alcohol Sales by Companies, (K Units), 2018-2023
Table 6. Global Hepatoprotective Drug Against Alcohol Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatoprotective Drug Against Alcohol Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Hepatoprotective Drug Against Alcohol Product Type
Table 9. List of Global Tier 1 Hepatoprotective Drug Against Alcohol Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatoprotective Drug Against Alcohol Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2018-2023
Table 15. By Type - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2024-2029
Table 16. By Application – Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2018-2023
Table 20. By Application - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2024-2029
Table 21. By Region – Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatoprotective Drug Against Alcohol Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2018-2023
Table 25. By Region - Global Hepatoprotective Drug Against Alcohol Sales (K Units), 2024-2029
Table 26. By Country - North America Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hepatoprotective Drug Against Alcohol Sales, (K Units), 2018-2023
Table 29. By Country - North America Hepatoprotective Drug Against Alcohol Sales, (K Units), 2024-2029
Table 30. By Country - Europe Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hepatoprotective Drug Against Alcohol Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hepatoprotective Drug Against Alcohol Sales, (K Units), 2024-2029
Table 34. By Region - Asia Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hepatoprotective Drug Against Alcohol Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hepatoprotective Drug Against Alcohol Sales, (K Units), 2024-2029
Table 38. By Country - South America Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hepatoprotective Drug Against Alcohol Sales, (K Units), 2018-2023
Table 41. By Country - South America Hepatoprotective Drug Against Alcohol Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Sales, (K Units), 2024-2029
Table 46. Livestamin Healthcare Company Summary
Table 47. Livestamin Healthcare Hepatoprotective Drug Against Alcohol Product Offerings
Table 48. Livestamin Healthcare Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Livestamin Healthcare Key News & Latest Developments
Table 50. The Himalaya Drug Company Company Summary
Table 51. The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Product Offerings
Table 52. The Himalaya Drug Company Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. The Himalaya Drug Company Key News & Latest Developments
Table 54. Mysha Health World Company Summary
Table 55. Mysha Health World Hepatoprotective Drug Against Alcohol Product Offerings
Table 56. Mysha Health World Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Mysha Health World Key News & Latest Developments
Table 58. Chambio Company Summary
Table 59. Chambio Hepatoprotective Drug Against Alcohol Product Offerings
Table 60. Chambio Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Chambio Key News & Latest Developments
Table 62. Noreva Biotech Company Summary
Table 63. Noreva Biotech Hepatoprotective Drug Against Alcohol Product Offerings
Table 64. Noreva Biotech Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Noreva Biotech Key News & Latest Developments
Table 66. Finecure Pharmaceuticals Limited Company Summary
Table 67. Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Product Offerings
Table 68. Finecure Pharmaceuticals Limited Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Finecure Pharmaceuticals Limited Key News & Latest Developments
Table 70. Iscon Life Sciences Company Summary
Table 71. Iscon Life Sciences Hepatoprotective Drug Against Alcohol Product Offerings
Table 72. Iscon Life Sciences Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Iscon Life Sciences Key News & Latest Developments
Table 74. Sunflower Pharmaceutical Group Co.,ltd. Company Summary
Table 75. Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Product Offerings
Table 76. Sunflower Pharmaceutical Group Co.,ltd. Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sunflower Pharmaceutical Group Co.,ltd. Key News & Latest Developments
Table 78. Swisse Company Summary
Table 79. Swisse Hepatoprotective Drug Against Alcohol Product Offerings
Table 80. Swisse Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Swisse Key News & Latest Developments
Table 82. By-health Co.,ltd Company Summary
Table 83. By-health Co.,ltd Hepatoprotective Drug Against Alcohol Product Offerings
Table 84. By-health Co.,ltd Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. By-health Co.,ltd Key News & Latest Developments
Table 86. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Summary
Table 87. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Product Offerings
Table 88. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 90. Xiuzheng Pharmaceutical Industry Group Company Company Summary
Table 91. Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Product Offerings
Table 92. Xiuzheng Pharmaceutical Industry Group Company Hepatoprotective Drug Against Alcohol Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Xiuzheng Pharmaceutical Industry Group Company Key News & Latest Developments
Table 94. Hepatoprotective Drug Against Alcohol Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Hepatoprotective Drug Against Alcohol Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Hepatoprotective Drug Against Alcohol Production by Region, 2018-2023 (K Units)
Table 97. Global Hepatoprotective Drug Against Alcohol Production by Region, 2024-2029 (K Units)
Table 98. Hepatoprotective Drug Against Alcohol Market Opportunities & Trends in Global Market
Table 99. Hepatoprotective Drug Against Alcohol Market Drivers in Global Market
Table 100. Hepatoprotective Drug Against Alcohol Market Restraints in Global Market
Table 101. Hepatoprotective Drug Against Alcohol Raw Materials
Table 102. Hepatoprotective Drug Against Alcohol Raw Materials Suppliers in Global Market
Table 103. Typical Hepatoprotective Drug Against Alcohol Downstream
Table 104. Hepatoprotective Drug Against Alcohol Downstream Clients in Global Market
Table 105. Hepatoprotective Drug Against Alcohol Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatoprotective Drug Against Alcohol Segment by Type in 2022
Figure 2. Hepatoprotective Drug Against Alcohol Segment by Application in 2022
Figure 3. Global Hepatoprotective Drug Against Alcohol Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatoprotective Drug Against Alcohol Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatoprotective Drug Against Alcohol Revenue, 2018-2029 (US$, Mn)
Figure 7. Hepatoprotective Drug Against Alcohol Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatoprotective Drug Against Alcohol Revenue in 2022
Figure 9. By Type - Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 12. By Type - Global Hepatoprotective Drug Against Alcohol Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 16. By Application - Global Hepatoprotective Drug Against Alcohol Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 21. By Country - North America Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 23. US Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 28. Germany Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 29. France Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 37. China Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 41. India Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 44. Brazil Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hepatoprotective Drug Against Alcohol Sales Market Share, 2018-2029
Figure 48. Turkey Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hepatoprotective Drug Against Alcohol Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hepatoprotective Drug Against Alcohol Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Hepatoprotective Drug Against Alcohol by Region, 2022 VS 2029
Figure 54. Hepatoprotective Drug Against Alcohol Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アルコール性肝障害治療薬の世界市場見通し2023年-2029年(Hepatoprotective Drug Against Alcohol Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

アルコール性肝障害治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp